Hospital Rankings for Stroke Outcomes Must Consider Stroke Severity
August 6, 2012|Vascular Specialist
Author and Disclosure Information
FROM JAMA
Dr. Kurth is in neuroepidemiology at the University of Bordeaux (France). Dr. Elkind is in the department of neurology in the school of medicine and the department of epidemiology in the school of public health at Columbia University, New York. Dr. Kurth reported ties to Allergan, Merck, and MAP Pharmaceuticals, and Dr. Elkind reported ties to diaDexus, Britol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Novartis, Organon, and GlaxoSmithKline.
Dr. Gregg C. Fonarow
